Basyouni Abuseif, country president and CPO Head at Novartis Egypt, explains how the Swiss company has taken over the leadership position in the Egyptian pharmaceutical market despite economic and political challenges. He also highlights recent achievements of the government in fighting Hepatitis C, while emphasizing the need for more attention on matters like pricing and clinical trials in the country.
Perhaps our most visible achievement has been our team’s ascension to – and maintaining of - the leadership position in the Egyptian pharmaceutical market
